Evidence map›Paper›PMID 34502165›Full record

ArticleInternational journal of molecular sciences2021

Eugenol-Induced Autophagy and Apoptosis in Breast Cancer Cells via PI3K/AKT/FOXO3a Pathway Inhibition.

Mashan L Abdullah, Othman Al-Shabanah, Zeinab K Hassan, Mohamed M Hafez

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. [Role and mechanisms of FoxO3a-related signaling pathways in breast cancer cell apoptosis].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Mashan L AbdullahExperimental Medicine Department, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, MNGHA, Riyadh 11426, Saudi Arabia.ORCID 0000-0002-4628-1536
Othman Al-ShabanahPharmacology and Toxicology Department, King Saud University, Riyadh 11426, Saudi Arabia.
Zeinab K HassanCancer Biology Department, National Cancer Institute, Cairo University, Cairo 12613, Egypt.
Mohamed M HafezCancer Biology Department, National Cancer Institute, Cairo University, Cairo 12613, Egypt.
Cairo University · EGKing Saud bin Abdulaziz University for Health Sciences · SAKing Saud University · SA

Funding

King Abdulaziz City for Science and Technology 1-17-03-001-0008
6 · The paper itself

Abstract

The use of natural compounds is promising in approaches to prevent and treat cancer. The long-term application of most currently employed chemotherapy techniques has toxic side effects. Eugenol, a phenolic phytochemical extracted from certain essential oils, has an anti-cancer effect. The modulation of autophagy can promote either the survival or apoptosis of cancer cells. Triple-negative (MDA-MB-231) and HER2 positive (SK-BR-3) breast cancer cell lines were treated with different doses of eugenol. Apoptosis was detected by a flow-cytometry technique, while autophagy was detected by acridine orange. Real-time PCR and Western blot assays were applied to investigate the effect of eugenol on the gene and protein expression levels of autophagy and apoptotic genes. Treating cells with different concentrations of eugenol significantly inhibited cell proliferation. The protein levels of AKT serine/threonine kinase 1 (AKT), forkhead box O3 (FOXO3a), cyclin dependent kinase inhibitor 1A (p21), cyclin-dependent kinase inhibitor (p27), and Caspase-3 and -9 increased significantly in Eugenol-treated cells. Eugenol also induced autophagy by upregulating the expression levels of microtubule-associated protein 1 light chain 3 (LC3) and downregulating the expression of nucleoporin 62 (NU p62). Eugenol is a promising natural anti-cancer agent against triple-negative and HER2-positive breast cancer. It appears to work by targeting the caspase pathway and by inducing autophagic cell death.

Indexed as

Antineoplastic AgentsApoptosisAutophagyBreast NeoplasmsCell Line, TumorCell ProliferationCyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent Kinase Inhibitor p27EugenolFemaleForkhead Box Protein O3HumansMembrane GlycoproteinsMicrotubule-Associated ProteinsNuclear Pore Complex ProteinsPhosphatidylinositol 3-KinasesAntineoplastic AgentsCyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent Kinase Inhibitor p27EugenolForkhead Box Protein O3FOXO3 protein, humanMAP1LC3A protein, humanMembrane GlycoproteinsMicrotubule-Associated ProteinsNuclear Pore Complex Proteinsnuclear pore protein p62Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktautophagyeugenolPI3K/AKT/FOXO3a pathwaytriple negative breast cancer

Identifiers

PMID34502165
PMCPMC8430664
OpenAlexW3195787174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.